Adaptive Biotechnologies Corp reports results for the quarter ended in March - Earnings Summary

Adaptive Biotechnologies

04/05/2023 24:29

* Adaptive Biotechnologies Corp  ADPT.OQ  reported a
quarterly
adjusted loss of 40 cents​​ per share for the quarter ended in
March. The mean expectation of ten analysts for the quarter was
for a loss of 38 cents per share.
    * Revenue fell 2.5% to $37.65 million from a year ago;
analysts
expected $36.81 million. 
    * Adaptive Biotechnologies Corp's reported EPS for the
quarter was
a loss of 40 cents​.
    * The mean earnings estimate of analysts had risen by
about 6.9%
in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates 
    * Adaptive Biotechnologies Corp shares had fallen by 20.6%
this
quarter and lost 8.2% so far this year.
    * The company reported a quarterly loss of $57.7 million.
    * Wall Street's median 12-month price target for Adaptive
Biotechnologies Corp is $12.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
3 at 11:29 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.38          -0.40          Missed
 Dec. 31 2022      -0.35          -0.28          Beat
 Sep. 30 2022      -0.38          -0.32          Beat
 Jun. 30 2022      -0.43          -0.37          Beat